$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000110465913080062 Filed on November 01, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$1.036M	$1.036M	$1.036M
YoY Change	0.0%	0.0%	-0.29%
Cost Of Revenue			$0.00
YoY Change			-100.0%
Gross Profit	$1.036M	$1.036M	$1.036M
YoY Change	0.0%	0.0%	0.29%
Gross Profit Margin	100.0%	100.0%	100.0%
Selling, General & Admin	$6.589M	$5.301M	$3.553M
YoY Change	42.03%	49.2%	28.45%
% of Gross Profit	636.0%	511.68%	342.95%
Research & Development	$6.713M	$6.982M	$10.49M
YoY Change	-35.69%	-33.45%	71.7%
% of Gross Profit	647.97%	673.94%	1012.64%
Depreciation & Amortization	$400.0K	$400.0K	$300.0K
YoY Change	33.33%	33.33%	50.0%
% of Gross Profit	38.61%	38.61%	28.96%
Operating Expenses	$13.30M	$12.28M	$14.04M
YoY Change	-11.78%	-12.54%	58.22%
Operating Profit	-$12.27M	-$11.25M	-$13.01M
YoY Change	-12.65%	-13.54%	65.85%
Interest Expense	$16.00K	$16.00K	$11.00K
YoY Change	-20.0%	45.45%	120.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$12.20M	-$11.20M	-$13.00M
YoY Change	-12.86%	-13.85%	66.67%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$12.20M	-$11.20M	-$13.00M
YoY Change	-12.86%	-13.85%	66.67%
Net Earnings / Revenue	-1177.61%	-1081.08%	-1254.83%
Basic Earnings Per Share
Diluted Earnings Per Share	-$172.3K	-$158.6K	-$214.9K
COMMON SHARES
Basic Shares Outstanding	70.92M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$133.3M	$147.8M	$118.6M
YoY Change	23.31%	24.62%	57.29%
Cash & Equivalents	$12.85M	$9.710M	$12.66M
Short-Term Investments	$120.4M	$138.1M	$105.9M
Other Short-Term Assets	$2.200M	$900.0K	$1.300M
YoY Change	266.67%	-30.77%	44.44%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$135.5M	$148.7M	$119.8M
YoY Change	24.6%	24.14%	57.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.17M	$6.751M	$3.629M
YoY Change	228.02%	86.03%	64.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$11.17M	$6.751M	$3.629M
YoY Change	228.02%	86.03%	64.95%
TOTAL ASSETS
Total Short-Term Assets	$135.5M	$148.7M	$119.8M
Total Long-Term Assets	$11.17M	$6.751M	$3.629M
Total Assets	$146.6M	$155.5M	$123.5M
YoY Change	30.78%	25.96%	57.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$761.0K	$605.0K	$1.030M
YoY Change	-79.16%	-41.26%	3.0%
Accrued Expenses	$5.806M	$5.725M	$4.084M
YoY Change	74.51%	40.18%	77.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$300.0K	$400.0K
YoY Change	33.33%	-25.0%
Total Short-Term Liabilities	$7.752M	$8.502M	$9.612M
YoY Change	-32.33%	-11.55%	29.89%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	0.0%
Other Long-Term Liabilities	$2.200M	$500.0K	$1.400M
YoY Change	450.0%	-64.29%	-74.55%
Total Long-Term Liabilities	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	-84.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.752M	$8.502M	$9.612M
Total Long-Term Liabilities	$1.000M	$1.000M	$1.000M
Total Liabilities	$8.752M	$9.502M	$10.61M
YoY Change	-29.73%	-10.46%	-23.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$320.8M	-$308.6M	-$260.3M
YoY Change	16.96%	18.56%
Common Stock	$456.0M	$453.5M	$370.8M
YoY Change	22.32%	22.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$135.3M	$145.1M	$110.7M
YoY Change
Total Liabilities & Shareholders Equity	$146.6M	$155.5M	$123.5M
YoY Change	30.78%	25.96%	57.26%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$12.20M	-$11.20M	-$13.00M
YoY Change	-12.86%	-13.85%	66.67%
Depreciation, Depletion And Amortization	$400.0K	$400.0K	$300.0K
YoY Change	33.33%	33.33%	50.0%
Cash From Operating Activities	-$10.30M	-$8.000M	-$10.30M
YoY Change	-0.96%	-22.33%	43.06%
INVESTING ACTIVITIES
Capital Expenditures	-$4.300M	-$2.700M	$100.0K
YoY Change	4200.0%	-2800.0%	-111.11%
Acquisitions
YoY Change
Other Investing Activities	$17.60M	-$2.000M	-$41.20M
YoY Change	60.0%	-95.15%	61.57%
Cash From Investing Activities	$13.20M	-$4.700M	-$41.10M
YoY Change	21.1%	-88.56%	55.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$57.80M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	900.0K	57.90M
YoY Change	50.0%	-98.45%	14375.0%
NET CHANGE
Cash From Operating Activities	-10.30M	-8.000M	-10.30M
Cash From Investing Activities	13.20M	-4.700M	-41.10M
Cash From Financing Activities	300.0K	900.0K	57.90M
Net Change In Cash	3.200M	-11.80M	6.500M
YoY Change	357.14%	-281.54%	-119.58%
FREE CASH FLOW
Cash From Operating Activities	-$10.30M	-$8.000M	-$10.30M
Capital Expenditures	-$4.300M	-$2.700M	$100.0K
Free Cash Flow	-$6.000M	-$5.300M	-$10.40M
YoY Change	-41.75%	-49.04%	65.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	250000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Consulting Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderConsultingAgreement	75000	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7576000	shares
CY2012Q2	exas	Vesting Rights Number Of Annual Installments VestingRightsNumberOfAnnualInstallments	3	item
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2012Q4	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	4051000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12913000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	106000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2012Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	824000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11455000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7625000	shares
	exas	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Under Licensing Agreement ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsUnderLicensingAgreement	80000	shares
	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORP
	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 20.15pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</font></p> </div>
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	70917521	shares
	exas	Minimum Contractual Term Of Certain Current Investments Which Can Be Liquidated MinimumContractualTermOfCertainCurrentInvestmentsWhichCanBeLiquidated	P1Y
CY2013Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	138013000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	94698000	USD
CY2012Q4	exas	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	78000	USD
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	138131000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	94776000	USD
CY2013Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14400000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M19D
CY2009Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	75000	shares
CY2013Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.01
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13345000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	94776000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	593000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	108714000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	5100	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4200	USD
	exas	Number Of Objectives Of Entitys Investment Strategy NumberOfObjectivesOfEntitysInvestmentStrategy	2	item
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	283000	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5186000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1781000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3405000	USD
CY2012Q4	us-gaap	Assets Assets	112119000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3652000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3327000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	333000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4143000	USD
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2547000	USD
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70897521	shares
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	39000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0276	pure
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70897521	shares
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue		USD
	exas	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.0138	pure
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q3	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63909800	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63909800	shares
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Licenses Revenue LicensesRevenue	3108000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10491000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31692000	USD
CY2012Q4	exas	Interest Payable Noncurrent InterestPayableNoncurrent	63000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	711000	USD
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	295000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	639000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	372123000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	78000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-274245000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	98595000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	112119000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	148745000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9436000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6751000	USD
CY2013Q3	us-gaap	Assets Assets	155496000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8502000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	145090000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155496000	USD
CY2013Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5660000	USD
CY2012Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1500000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4024000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7085000	USD
CY2012Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1006000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2931000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	14044000	USD
	us-gaap	Operating Expenses OperatingExpenses	41708000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13008000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-38600000	USD
CY2012Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	67000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	188000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11247000	USD
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	60531000	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-34495000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11160000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	58104000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	66389000	shares
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	12283000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	11000	USD
	us-gaap	Interest Expense InterestExpense	21000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38433000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34328000	USD
	us-gaap	Operating Expenses OperatingExpenses	37603000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.66
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3686000	USD
CY2013Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1615000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34288000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38327000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11059000	USD
	us-gaap	Depreciation Depreciation	666000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-91000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	59845000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-3108000	USD
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	152000	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	1000000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	359000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	218000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	265000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1483000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-33795000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	90408000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	41823000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	586000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-49171000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	57755000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2090000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-23121000	USD
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	248000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-29709000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-48186000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	74260000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-3635000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	106000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	274000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	194000	USD
	us-gaap	Payments To Acquire Equipment On Lease PaymentsToAcquireEquipmentOnLease	1151000	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	261000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Employer Contribution DeferredCompensationArrangementWithIndividualEmployerContribution	354000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	40000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35781000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12660000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9710000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	30534	shares
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	32872	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	34442	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	34336	shares
CY2013Q3	exas	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	118000	USD
CY2013Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	138131000	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	904000	USD
CY2013Q3	exas	Laboratory Equipment Gross LaboratoryEquipmentGross	4546000	USD
CY2013Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	855000	USD
CY2013Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	339000	USD
CY2013Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	28000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2685000	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	605000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5725000	USD
CY2013Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	347000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1330000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	USD
CY2013Q3	exas	Interest Payable Noncurrent InterestPayableNoncurrent	79000	USD
CY2013Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	449000	USD
CY2013Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	103000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	16000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	452836000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	709000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	118000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308573000	USD
CY2013Q3	us-gaap	Licenses Revenue LicensesRevenue	1036000	USD
	us-gaap	Licenses Revenue LicensesRevenue	3108000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6982000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20965000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9962000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6676000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	220000	USD
	us-gaap	Interest Expense InterestExpense	53000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	101000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	40000	USD
	us-gaap	Depreciation Depreciation	976000	USD
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	-3108000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	458000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	311000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3047000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3013000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	16000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	89261000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	45488000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4413000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	73296000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1212000	USD
CY2013Q3	us-gaap	Lease Incentive Payable Current LeaseIncentivePayableCurrent	495000	USD
CY2013Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3668000	USD
CY2013Q3	exas	Lease Incentive Payable Noncurrent LeaseIncentivePayableNoncurrent	376000	USD
CY2013Q2	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P5Y
CY2013Q2	exas	Operating Lease Area Under Lease OperatingLeaseAreaUnderLease	29000
CY2013Q2	exas	Number Of Extensions Of Lease Term NumberOfExtensionsOfLeaseTerm	2	item
CY2013Q3	us-gaap	Lease Incentive Payable Current And Noncurrent LeaseIncentivePayableCurrentAndNoncurrent	900000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	112000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	676000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	680000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	684000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	689000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	578000	USD
CY2013Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3419000	USD
	exas	Increase Decrease In Lease Incentive Payable IncreaseDecreaseInLeaseIncentivePayable	871000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	14800	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	4800	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	85409000	USD
CY2013Q3	exas	Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost	52604000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	138013000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	85452000	USD
CY2013Q3	exas	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	52679000	USD
CY2013Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD

Files In Submission

Name	View Source	Status
0001104659-13-080062-index-headers.html	Edgar Link	pending
0001104659-13-080062-index.html	Edgar Link	pending
0001104659-13-080062.txt	Edgar Link	pending
0001104659-13-080062-xbrl.zip	Edgar Link	pending
a13-19530_110q.htm	Edgar Link	pending
a13-19530_1ex10d1.htm	Edgar Link	pending
a13-19530_1ex10d2.htm	Edgar Link	pending
a13-19530_1ex10d4.htm	Edgar Link	pending
a13-19530_1ex31d1.htm	Edgar Link	pending
a13-19530_1ex31d2.htm	Edgar Link	pending
a13-19530_1ex32d1.htm	Edgar Link	pending
exas-20130930.xml	Edgar Link	completed
exas-20130930.xsd	Edgar Link	pending
exas-20130930_cal.xml	Edgar Link	unprocessable
exas-20130930_def.xml	Edgar Link	unprocessable
exas-20130930_lab.xml	Edgar Link	unprocessable
exas-20130930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g195301kei001.jpg	Edgar Link	pending
g195301kei002.jpg	Edgar Link	pending
g195301kgi001.jpg	Edgar Link	pending
g195301kgi002.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2013 Q4 Form 10-Q Financial Statement

#000110465913080062 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2013 Q4 Form 10-Q Financial Statement

#000110465913080062 Filed on November 01, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas